Teladoc Health, Inc. (NYSE:TDOC) Stake Trimmed by Entropy Technologies LP

Entropy Technologies LP cut its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 52.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 85,660 shares of the health services provider’s stock after selling 93,877 shares during the quarter. Entropy Technologies LP’s holdings in Teladoc Health were worth $779,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in TDOC. Murphy Pohlad Asset Management LLC purchased a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $458,000. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Teladoc Health by 21.8% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock valued at $6,365,000 after purchasing an additional 125,111 shares in the last quarter. KBC Group NV lifted its holdings in shares of Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 3,714 shares in the last quarter. Westside Investment Management Inc. boosted its position in shares of Teladoc Health by 43.8% in the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after buying an additional 2,800 shares during the period. Finally, Nisa Investment Advisors LLC grew its holdings in shares of Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after buying an additional 424,180 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.95% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on TDOC. Barclays raised their price objective on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. TD Cowen decreased their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. The Goldman Sachs Group started coverage on shares of Teladoc Health in a report on Friday, November 15th. They set a “buy” rating and a $14.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Fourteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $11.97.

Teladoc Health Stock Performance

Shares of Teladoc Health stock opened at $12.99 on Wednesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm has a 50 day simple moving average of $10.13 and a 200 day simple moving average of $9.20. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $21.74. The firm has a market cap of $2.24 billion, a P/E ratio of -2.25 and a beta of 1.04.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.